FGFR1 and type 2 diabetes mellitus: Taken together, the results of this report strongly suggest that carriers of deleterious FGFR1 SNVs and those possibly those harboring FGFR1 common risk alleles should also be considered at higher risk of T2D and should be monitored for the development of the disease.